Details

Autor(en) / Beteiligte

• Natale, Fabio
• De Curtis, Mario
• Schornagel, Fleurtje A
• Oudesluys-Murphy, Anne M
• Vossen, Ann C
• Korndewal, Marjolein J
• de Vries, Jutte J.C
• de Melker, Hester E
• Kimberlin, David W
• Aban, Inmaculada
• Acosta, Edward P

Titel

Valganciclovir for Congenital Cytomegalovirus

Ist Teil von

• The New England journal of medicine, 2015-06, Vol.372 (25), p.2462-2463

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2015

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• To the Editor: In the treatment of congenital cytomegalovirus infection, administration of valganciclovir therapy for 6 months is four times as long as administration for 6 weeks. In this regard, Kimberlin et al. (March 5 issue) 1 do not underscore an important finding of their study; in fact, a comparison of the trends of the viral load in whole blood in the two study groups shows that a significant difference (in favor of the patients who received valganciclovir for 6 months) was evident only from day 56 until day 84, whereas no difference was detectable from 4 to 6 months of . . .